The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Tauopathies Treatment Market Research Report 2024

Global Tauopathies Treatment Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1885411

No of Pages : 63

Synopsis
The global Tauopathies Treatment market was valued at US$ 808.9 million in 2023 and is anticipated to reach US$ 1453.8 million by 2030, witnessing a CAGR of 8.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tauopathies Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tauopathies Treatment.
Report Scope
The Tauopathies Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tauopathies Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tauopathies Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb Company
Selvita S.A
SK Biopharmaceuticals Co., Ltd.
Chronos Therapeutics Limited
Segment by Type
SEL-141
RDC-5
YM-08
Thiamet-G
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tauopathies Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tauopathies Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 SEL-141
1.2.3 RDC-5
1.2.4 YM-08
1.2.5 Thiamet-G
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tauopathies Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tauopathies Treatment Market Perspective (2019-2030)
2.2 Tauopathies Treatment Growth Trends by Region
2.2.1 Global Tauopathies Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tauopathies Treatment Historic Market Size by Region (2019-2024)
2.2.3 Tauopathies Treatment Forecasted Market Size by Region (2025-2030)
2.3 Tauopathies Treatment Market Dynamics
2.3.1 Tauopathies Treatment Industry Trends
2.3.2 Tauopathies Treatment Market Drivers
2.3.3 Tauopathies Treatment Market Challenges
2.3.4 Tauopathies Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tauopathies Treatment Players by Revenue
3.1.1 Global Top Tauopathies Treatment Players by Revenue (2019-2024)
3.1.2 Global Tauopathies Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Tauopathies Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tauopathies Treatment Revenue
3.4 Global Tauopathies Treatment Market Concentration Ratio
3.4.1 Global Tauopathies Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tauopathies Treatment Revenue in 2023
3.5 Tauopathies Treatment Key Players Head office and Area Served
3.6 Key Players Tauopathies Treatment Product Solution and Service
3.7 Date of Enter into Tauopathies Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tauopathies Treatment Breakdown Data by Type
4.1 Global Tauopathies Treatment Historic Market Size by Type (2019-2024)
4.2 Global Tauopathies Treatment Forecasted Market Size by Type (2025-2030)
5 Tauopathies Treatment Breakdown Data by Application
5.1 Global Tauopathies Treatment Historic Market Size by Application (2019-2024)
5.2 Global Tauopathies Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tauopathies Treatment Market Size (2019-2030)
6.2 North America Tauopathies Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tauopathies Treatment Market Size by Country (2019-2024)
6.4 North America Tauopathies Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tauopathies Treatment Market Size (2019-2030)
7.2 Europe Tauopathies Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tauopathies Treatment Market Size by Country (2019-2024)
7.4 Europe Tauopathies Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tauopathies Treatment Market Size (2019-2030)
8.2 Asia-Pacific Tauopathies Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tauopathies Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Tauopathies Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tauopathies Treatment Market Size (2019-2030)
9.2 Latin America Tauopathies Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tauopathies Treatment Market Size by Country (2019-2024)
9.4 Latin America Tauopathies Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tauopathies Treatment Market Size (2019-2030)
10.2 Middle East & Africa Tauopathies Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tauopathies Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Tauopathies Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb Company
11.1.1 Bristol-Myers Squibb Company Company Detail
11.1.2 Bristol-Myers Squibb Company Business Overview
11.1.3 Bristol-Myers Squibb Company Tauopathies Treatment Introduction
11.1.4 Bristol-Myers Squibb Company Revenue in Tauopathies Treatment Business (2019-2024)
11.1.5 Bristol-Myers Squibb Company Recent Development
11.2 Selvita S.A
11.2.1 Selvita S.A Company Detail
11.2.2 Selvita S.A Business Overview
11.2.3 Selvita S.A Tauopathies Treatment Introduction
11.2.4 Selvita S.A Revenue in Tauopathies Treatment Business (2019-2024)
11.2.5 Selvita S.A Recent Development
11.3 SK Biopharmaceuticals Co., Ltd.
11.3.1 SK Biopharmaceuticals Co., Ltd. Company Detail
11.3.2 SK Biopharmaceuticals Co., Ltd. Business Overview
11.3.3 SK Biopharmaceuticals Co., Ltd. Tauopathies Treatment Introduction
11.3.4 SK Biopharmaceuticals Co., Ltd. Revenue in Tauopathies Treatment Business (2019-2024)
11.3.5 SK Biopharmaceuticals Co., Ltd. Recent Development
11.4 Chronos Therapeutics Limited
11.4.1 Chronos Therapeutics Limited Company Detail
11.4.2 Chronos Therapeutics Limited Business Overview
11.4.3 Chronos Therapeutics Limited Tauopathies Treatment Introduction
11.4.4 Chronos Therapeutics Limited Revenue in Tauopathies Treatment Business (2019-2024)
11.4.5 Chronos Therapeutics Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’